Finally, the comparison of MDS‐UPDRS and DAT binding in years 1 to 4 is confounded by the profound treatment effect of PD medications on motor MDS‐UPDRS scores, although the analysis was run for the OFF scores. The gene discussed is SLC6A3; the disease is Parkinson disease.